Adipose-Derived Micrograft Enrichment with Autologous Growth Factors: A Novel Paradigm in Natural Body Contouring through Regenerative Adipogenesis and Stromal Vascular Fraction-Mediated Neovascularization
Main Article Content
Abstract
The evolving field of regenerative aesthetic medicine continues to seek minimally invasive methodologies that provide natural, durable outcomes in body contouring. This article elucidates the scientific rationale and clinical efficacy of autologous fat grafting, specifically through the technique of microfat harvesting and processing, augmented with the concentrated release of endogenous growth factors derived from activated platelet-rich plasma (PRP) or platelet-rich fibrin (PRF). We posit that this synergistic combination transcends the conventional model of mere volume restoration, advancing into a holistic paradigm of in situ tissue regeneration. The core mechanism hinges on the bioactive interplay between the adipose-derived stem cells (ASCs) and endothelial progenitor cells within the stromal vascular fraction (SVF) of the micrografts and the potent cytokine cocktail—including platelet-derived growth factor (PDGF), vascular endothelial growth factor (VEGF), and transforming growth factor-beta (TGF-β)—released from the platelets. Current evidence underscores that this microenvironment significantly enhances graft viability by promoting early angiogenesis, mitigating apoptotic cell death, and fostering adipocyte progenitor differentiation. Furthermore, we review contemporary high-level clinical studies and systematic analyses that demonstrate superior volumetric retention, improved cutaneous quality, and reduced postoperative resorption rates compared to traditional lipofilling. This manuscript provides a comprehensive synthesis of the current biological understanding, technical protocols for optimized bio-activation, and clinical applications, positioning growth factor-enriched adipose micrografts as a cornerstone in the pursuit of natural, structural body remodeling.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Hong KY, Yim S, Kim HJ, Jin US, Lim S, Eo S, et al. The fate of the adipose-derived stromal cells during angiogenesis and adipogenesis after cell-assisted lipotransfer. Plast Reconstr Surg. 2018;141:365–75.
doi: 10.1097/PRS.0000000000004021.
II. Strong AL, Cederna PS, Rubin JP, Coleman SR, Levi B. The current state of fat grafting: a review of harvesting, processing, and injection techniques. Plast Reconstr Surg. 2015;136:897–912.
doi: 10.1097/PRS.0000000000001590.
III. Khouri RK, Jr, Khouri RK. Current clinical applications of fat grafting. Plast Reconstr Surg. 2017;140:466e–486e.
doi: 10.1097/PRS.0000000000003648.
IV. Tonnard P, Verpaele A, Peeters G, Hamdi M, Cornelissen M, Declercq H. Nanofat grafting: basic research and clinical applications. Plast Reconstr Surg. 2013;132:1017–26.
doi: 10.1097/PRS.0b013e31829fe1b0.
V. Suszynski TM, Sieber DA, Van Beek AL, Cunningham BL. Characterization of adipose tissue for autologous fat grafting. Aesthet Surg J. 2015;35:194–203. doi: 10.1093/asj/sju059.
VI. Hassan M, Latif N, Yacoub M. Adipose tissue: friend or foe? Nat Rev Cardiol. 2012;9:689–702. doi: 10.1038/nrcardio.2012.148.
VII. Rosen ED, Spiegelman BM. Adipocytes as regulators of energy balance and glucose homeostasis. Nature. 2006;444:847–53.
doi: 10.1038/nature05483.
VIII. Adams KF, Schatzkin A, Harris TB, Kipnis V, Mouw T, Ballard-Barbash R, et al. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med. 2006;355:763–78. doi: 10.1056/NEJMoa055643.
IX. Trayhurn P. Adipocyte biology. Obes Rev. 2007;8 Suppl 1:41–4.
doi: 10.1111/j.1467-789X.2007.00316.x.
X. Berry DC, Stenesen D, Zeve D, Graff JM. The developmental origins of adipose tissue. Development. 2013;140:3939–49.
doi: 10.1242/dev.080549.
XI. Rupnick MA, Panigrahy D, Zhang CY, Dallabrida SM, Lowell BB, Langer R, et al. Adipose tissue mass can be regulated through the vasculature. Proc Natl Acad Sci U S A. 2002;99:10730–5. doi: 10.1073/pnas.162349799.
XII. Eto H, Kato H, Suga H, Aoi N, Doi K, Kuno S, et al. The fate of adipocytes after nonvascularized fat grafting: evidence of early death and replacement of adipocytes. Plast Reconstr Surg. 2012;129:1081–92. doi: 10.1097/PRS.0b013e31824a2b19.
XIII. Kato H, Mineda K, Eto H, Doi K, Kuno S, Kinoshita K, et al. Degeneration, regeneration, and cicatrization after fat grafting: dynamic total tissue remodeling during the first 3 months. Plast Reconstr Surg. 2014;133:303e–313e.
doi: 10.1097/PRS.0000000000000066.
XIV. Schaffler A, Buchler C. Concise review: adipose tissue-derived stromal cells: basic and clinical implications for novel cell-based therapies. Stem Cells. 2007;25:818–27.
doi: 10.1634/stemcells.2006-0589.
XV. Ashjian PH, Elbarbary AS, Edmonds B, DeUgarte D, Zhu M, Zuk PA, et al. In vitro differentiation of human processed lipoaspirate cells into early neural progenitors. Plast Reconstr Surg. 2003;111:1922–31. doi: 10.1097/01.PRS.0000055043.62589.05.